Press "Enter" to skip to content

New patent for Heron Theraps drug CINVANTI

1
Copyright © DrugPatentWatch. Originally published at New patent for Heron Theraps drug CINVANTI

Annual Drug Patent Expirations for CINVANTI
Annual Drug Patent Expirations for CINVANTI

Cinvanti is a drug marketed by Heron Theraps Inc and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.

This drug has seven patent family members in five countries.

The generic ingredient in CINVANTI is aprepitant. One supplier is listed for this compound. Additional details are available on the aprepitant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Heron Theraps drug CINVANTI

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions